N-Acetyl Selank · Cognitive
N-Acetyl Selank dosage by bodyweight
Reference dose ranges scaled across bodyweight bands, anchored to the most-cited research dose (400 mcg @ 75 kg). Educational only, never a recommendation.
| Bodyweight band | Reference dose range | At U-100 (1 mg/mL) | Vol. on U-100 (5 mg / 2 mL) | 5× t½ elapsed |
|---|---|---|---|---|
| <60 kg / <132 lb | 249–337 mcg | 0.25–0.34 mL | 10–14 units0.10–0.13 mL | – |
| 60–75 kg / 132–165 lb | 306–414 mcg | 0.31–0.41 mL | 12–17 units0.12–0.17 mL | – |
| 75–90 kg / 165–198 lb | 374–506 mcg | 0.37–0.51 mL | 15–20 units0.15–0.20 mL | – |
| 90–105 kg / 198–231 lb | 442–598 mcg | 0.44–0.60 mL | 18–24 units0.18–0.24 mL | – |
| >105 kg / >231 lb | 510–690 mcg | 0.51–0.69 mL | 20–28 units0.20–0.28 mL | – |
Volume column assumes a standard 5 mg vial reconstituted with 2 mL bacteriostatic water (concentration 2.5 mg/mL); insulin units shown for a U-100 syringe. No published half-life on file for N-Acetyl Selank; the elapsed-time column is hidden.
Dose & PK references
Selected from the N-Acetyl Selank bibliography for relevance to dosing and pharmacokinetics.
- Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission
- [Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia]
- Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.